Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Prostate Cancer
Interventions
DRUG

Degarelix

Trial Locations (15)

Unknown

Urology Centers of Alabama, Homewood

South Orange County Urology Research, Laguna Hills

San Bernadino Urological Association, San Bernadino

South Florida Medical Research, Aventura

Premier Medical Group of the Hudson Valley, Poughkeepsie

Carolina Clinical Trials, Concord

Carolina Urologic Research Center, Myrtle Beach

Urology Clinic of North Texas, Dallas

Urology San Antonio Research, Pa, San Antonio

Pacific Urologic Research, Victoria

Euroscope Inc, Barrie

Bramalea Medical Centre, Brampton

Urology Associates/Urologic Medical Research, Kitchener

Office of Dr. Bernard Goldfarb, North Bay

Urology South Shore Research, Greenfield Park

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY